Cargando…

Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine

Immune checkpoint blockade (ICB) therapies, which potentiate the body’s natural immune response against tumor cells, have shown immense promise in the treatment of various cancers. Currently, tumor mutational burden (TMB) and programmed death ligand 1 (PD-L1) expression are the primary biomarkers ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conway, Jake R., Kofman, Eric, Mo, Shirley S., Elmarakeby, Haitham, Van Allen, Eliezer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264032/ https://www.ncbi.nlm.nih.gov/pubmed/30497521 http://dx.doi.org/10.1186/s13073-018-0605-7

Ejemplares similares

Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer
por: Liu, Xiaoming, et al.
Publicado: (2017)

Artificial intelligence-aided clinical annotation of a large multi-cancer genomic dataset
por: Kehl, Kenneth L., et al.
Publicado: (2021)

Delivering on the promise of precision cancer medicine
por: Berger, Michael F., et al.
Publicado: (2016)

Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine
por: Lérias, Joana R., et al.
Publicado: (2019)

Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancer
por: Ghiringhelli, Francois, et al.
Publicado: (2018)

CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
por: Liu, Delong
Publicado: (2019)

Empirical evaluation of language modeling to ascertain cancer outcomes from clinical text reports
por: Elmarakeby, Haitham A., et al.
Publicado: (2023)

Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know
por: Braschi-Amirfarzan, Marta, et al.
Publicado: (2017)

Similarity-Based Codes Sequentially Assigned to Ebolavirus Genomes Are Informative of Species Membership, Associated Outbreaks, and Transmission Chains
por: Weisberg, Alexandra J., et al.
Publicado: (2015)

Systematic auditing is essential to debiasing machine learning in biology
por: Eid, Fatma-Elzahraa, et al.
Publicado: (2021)

Clinical Inflection Point Detection on the Basis of EHR Data to Identify Clinical Trial–Ready Patients With Cancer
por: Kehl, Kenneth L., et al.
Publicado: (2021)

The fuzzy world of precision medicine: deliberations of a precision medicine tumor board
por: McGraw, Sarah A, et al.
Publicado: (2017)

The U.S. National Library of Medicine’s impact on precision and genomic medicine
por: Mo, Huan, et al.
Publicado: (2022)

Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers
por: Eso, Yuji, et al.
Publicado: (2019)

Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy
por: Heij, Lara, et al.
Publicado: (2023)

Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies
por: Goodman, Aaron M., et al.
Publicado: (2017)

Precision medicine and implications in medical education
por: Lamichhane, Pratik, et al.
Publicado: (2023)

Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy
por: Delombaerde, D., et al.
Publicado: (2021)

A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine
por: Van Allen, Eliezer M., et al.
Publicado: (2016)

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
por: Miao, Diana, et al.
Publicado: (2018)

p53 activation: a checkpoint for precision genome editing?
por: Conti, Anastasia, et al.
Publicado: (2018)

The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine
por: Garofalo, Andrea, et al.
Publicado: (2016)

Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine
por: Nagahashi, Masayuki, et al.
Publicado: (2016)

Personal genomes and precision medicine
por: Highnam, Gareth, et al.
Publicado: (2012)

Personal genomes to precision medicine
por: Scaria, Vinod
Publicado: (2014)

Clinical genomics and precision medicine
por: Pena, Sérgio D. J., et al.
Publicado: (2022)

Immune Checkpoints Contribute Corneal Immune Privilege: Implications for Dry Eye Associated with Checkpoint Inhibitors
por: Hori, Junko, et al.
Publicado: (2020)

Metabolic Implications of Immune Checkpoint Proteins in Cancer
por: Stirling, Elizabeth R., et al.
Publicado: (2022)

Editorial: Artificial Intelligence for Precision Medicine
por: Deng, Jun, et al.
Publicado: (2022)

Precision medicine and therapies of the future
por: Sisodiya, Sanjay M.
Publicado: (2020)

Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
por: Takamatsu, Shiro, et al.
Publicado: (2022)

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?
por: Nijland, Marcel, et al.
Publicado: (2017)

Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies
por: Panikker, Priyalakshmi, et al.
Publicado: (2022)

Transforming of the Tumor Microenvironment: Implications for TGF-β Inhibition in the Context of Immune-Checkpoint Therapy
por: Löffek, Stefanie
Publicado: (2018)

Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy
por: Chen, Xingyu, et al.
Publicado: (2021)

Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy
por: Kavun, Alexandra, et al.
Publicado: (2023)

Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians
por: Zhou, Huijie, et al.
Publicado: (2023)

Rare immune diseases paving the road for genome editing-based precision medicine
por: Pavel-Dinu, Mara, et al.
Publicado: (2023)

The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment
por: Gong, Lanqi, et al.
Publicado: (2021)

Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
por: Koyama, Shohei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_43uel8lnr1s5jae8jtt5a13s8d